Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds.
- DOI
- 10.1177/14230380261466593
- Published
- 2026 Jan-Dec
- Container
- Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/14230380261466593,
title = {Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds.},
author = {Filella X},
year = {2026},
journal = {Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine},
doi = {10.1177/14230380261466593},
url = {https://doi.org/10.1177/14230380261466593}
}RIS
TY - JOUR TI - Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds. AU - Filella X PY - 2026 JO - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine DO - 10.1177/14230380261466593 UR - https://doi.org/10.1177/14230380261466593 ER -
APA
X, F. (2026). Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds.. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. https://doi.org/10.1177/14230380261466593
Source records
- pubmed · retrieved 2026-09-26T21:51:26.127Z